Next 10 |
2024-06-11 18:03:08 ET Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 09:20 AM ET Company Participants Scott Smith - CEO Theodora Mistras - CFO Philippe Martin - Chief R&D Officer Conference Call Participants ...
2024-06-11 14:46:20 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Tran...
2024-06-07 10:57:58 ET Summary Since Richard Francis became CEO in early 2023, his 'Pivot to Growth' strategy has continued to bear fruit. On April 16, the FDA approved Selarsdi, a biosimilar of Stelara, which earned Johnson & Johnson about $2.45 billion in the first quarter o...
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PITTSBURGH , June 7, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024 , before the...
2024-06-06 14:12:06 ET Viatris Inc. (VTRS) Jefferies 2024 Global Healthcare Conference Call June 6, 2024 08:00 ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Co...
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire PITTSBURGH , June 4, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sa...
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors PR Newswire PITTSBURGH , June 3, 2024 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, R...
Viatris to Participate in the Jeffries Global Healthcare Conference PR Newswire PITTSBURGH , May 31, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Jeffries Global Healthcare ...
2024-05-30 18:16:29 ET Summary Viatris Inc. reported Q1 2024 results in line with expectations, with a 2% decline in net sales. The company's EBITDA and free cash flow have been negatively impacted by declining sales, and its debt to EBITDA ratio remains high. Despite the low ...
2024-05-27 10:47:04 ET Southwest Airlines Co (LUV) LUV is trading DOWN for the last 4 days, and it at trading at $27.02 with volume of 6,830,596 and a one day change of $-0.40 (-1.46%). Southwest Airlines Co has a 52-week low of 21.91 and a 52-week high of $39.53. The business's 50-...
News, Short Squeeze, Breakout and More Instantly...
Viatris Inc. Company Name:
VTRS Stock Symbol:
NASDAQ Market:
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PITTSBURGH , June 7, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024 , before the...
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire PITTSBURGH , June 4, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sa...
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors PR Newswire PITTSBURGH , June 3, 2024 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, R...